RESUMEN
Catalytic properties and conformational stability of aminoacylase (N-acylamino acid amidohydrolase, EC 3.5.1.14) were studied in water-N,N-dimethylformamide (DMF) and water-dioxane solvent mixtures. Beside the prompt inhibition the solvents caused further inactivation during incubations. In the presence of 5% DMF content the inactivation proceeds with a well-measurable rate (t1/2 39 min), while in the case of 20% DMF the enzyme practically lost its starting activity during 50 min incubation (t1/2 13 min). The K(m) value of the enzyme increased about three times with increasing DMF concentrations up to about 2.6 M DMF, while the Vmax value decreased practically to zero in the same concentration range.
Asunto(s)
Amidohidrolasas/química , Amidohidrolasas/metabolismo , Amidohidrolasas/efectos de los fármacos , Dimetilformamida/química , Dimetilformamida/farmacología , Dioxanos/química , Dioxanos/farmacología , Estabilidad de Enzimas , Cinética , SolventesRESUMEN
The possibilities of exact measuring the effect of metal ions on the activity of phosphofructokinase (PFK) by means of both a heat inactivation and an auxiliary enzyme system were studied. It was found that both methods are suitable for measuring the inhibition of phosphofructokinase by metal ions. It was further found that metal ion concentrations causing 50% deactivation of PFK could not considerably influence the measuring capacity of the auxiliary enzyme system.
Asunto(s)
Contaminación Ambiental/efectos adversos , Metales/toxicidad , Músculo Esquelético/enzimología , Fosfofructoquinasa-1/antagonistas & inhibidores , Ácido Ascórbico/química , Calor , Músculo Esquelético/efectos de los fármacos , Desnaturalización ProteicaRESUMEN
[1,4]Benzodioxanylmethyl-, [1,4]benzodioxanylmethylaminopropyl- and phenoxyethylaminoethyl-substituted lactams were synthesised and their hypotensive activity was investigated. Some of these compounds show moderate to high hypotensive effect, but they had more toxic and/or side effects than GYKI-12 743.
Asunto(s)
Antihipertensivos/síntesis química , Antihipertensivos/farmacología , Dioxanos/síntesis química , Dioxanos/farmacología , Piridazinas/síntesis química , Piridazinas/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , GatosRESUMEN
4-(3-Pyridyl)thiazole and 2-methylimidazo[1,2-a]pyridine derivatives with anticholinergic antisecretory activity were synthesized. Most of the compounds (3-16) were formed from carbohydrazide 2 and carbonitrile 9. Some thiazole derivatives, most of them containing nitrogen attached to the thiazole C-2 (19-20), were prepared from 17 and 18 by known method. Compounds 12 and 19b exerted a significant antisecretory whereas 5b, 12 and 19b an antiulcer activity.
Asunto(s)
Antiulcerosos/síntesis química , Ácido Gástrico/metabolismo , Piridinas/síntesis química , Tiazoles/síntesis química , Animales , Fenómenos Químicos , Química Física , Femenino , Piridinas/farmacología , Ratas , Espectrofotometría Infrarroja , Tiazoles/farmacologíaRESUMEN
It was found that the 2,5-diaminobenzoic acid derivatives 1 activating the biosynthesis of prostaglandins have CNS side effects. The replacement of the 2-NH group in 1 by O or S resulted an inhibition of prostaglandin biosynthesis and increased CNS activity.
Asunto(s)
Aminobenzoatos/síntesis química , Depresores del Sistema Nervioso Central/síntesis química , Prostaglandinas/biosíntesis , Aminobenzoatos/farmacología , Animales , Anticonvulsivantes/síntesis química , Hipnóticos y Sedantes/síntesis química , Espectroscopía de Resonancia Magnética , Ratones , Espectrofotometría InfrarrojaRESUMEN
Thiazole derivatives with potential positive inotropic effect were synthesized. The highest activity (medium positive inotropic effect) was exhibited by ethyl 2-(2-hydroxyethylamino)-4-phenylthiazole-5-carboxylate (3b) of which several derivatives have been prepared. Among these derivatives only those which could presumably easily removed in the living organism to give 3b exhibited a medium positive inotropic effect (6, 8b). It was assumed that the effect of 3b had a beta-agonist character.
Asunto(s)
Cardiotónicos/síntesis química , Tiazoles/síntesis química , Animales , Gatos , Fenómenos Químicos , Química , Frecuencia Cardíaca/efectos de los fármacos , Propranolol/farmacología , Tiazoles/farmacologíaRESUMEN
The structure of 7,8-dihydro-6H-pyrimido [1,2-b]-1,2,4-triazolo [3,4-f] pyridazine (2a) was confirmed by 1H and 13C NMR spectroscopy and by preparation of the isomeric [5,1-f] pyridazine 3. Some derivatives of 6H-pyrimido [1,2-b]-1,2,4,-triazolo [3,4-f]pyridazine were prepared. Compounds 2a, 2b and 9a showed a positive inotropic effect.
Asunto(s)
Cardiotónicos/síntesis química , Piridazinas/síntesis química , Pirimidinonas/síntesis química , Triazoles/síntesis química , Animales , Fenómenos Químicos , Química Física , Espectroscopía de Resonancia MagnéticaRESUMEN
6-Substituted-[1,2,4]triazolo[4,3-b]pyridazine-3-methanol, -aldehyde, -nitrile, -chloromethyl and -aminomethyl derivatives of potential antihypertensive activity were synthesized. The reduction of methyl[1,2,4]triazolo[4,3-b] pyridazine-3-carboxylate by lithium aluminium hydride and potassium borohydride was examined. The new compounds failed to exhibit hypotensive or antihypertensive effect. Compound 2a was a minor metabolite of GYKI-11679 [7].